Cancer Alliance, represented by SECTION27, take on multinational company for excessive pricing case on breast cancer drug
The Cancer Alliance, represented by SECTION27, has been admitted by the Competition Tribunal as an intervening party in the excessive pricing case initiated by the Competition Commission. The case is against Switzerland-based multinational healthcare company, Roche Holdings AG and its subsidiaries (collectively referred to as Roche). The Competition Commission lodged Continue Reading
